Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
I think he will be the right leader in terms of communication and vision because he's already very well known and liked within the organization," Sherman tells Yahoo Finance ... and Vertex (VRTX) as ...
BMO Capital Markets managing director of biopharma equity research Evan Seigerman joins Market Domination to discuss the best ...
According to Benzinga Pro, Vertex Pharmaceuticals's peer group average for short interest as a percentage of float is 6.15%, ...
Barclays has recently reduced Vertex Pharmaceuticals Incorporated (VRTX) stock to Equal Weight rating, as announced on August 5, 2024, according to Finviz. Earlier, on June 27, 2024, Redburn Atlantic ...
Vertex Pharmaceuticals (VRTX) closed at $489.43 in the latest trading session, marking a +0.84% move from the prior day.